XTLB
$2.37
Xtl Biopharma Ads
($.07)
(2.87%)
XTLB
Earnings Whisper ®
N/A
Consensus:  $0.00
Revenue:  N/A
Monday
Jun 10
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when XTLB reports earnings?
Beat
Meet
Miss

Where is XTLB's stock price going from here?
Up
Flat
Down
Stock chart of XTLB
Analysts
Summary of analysts' recommendations for XTLB
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
XTL Biopharmaceuticals Ltd. is a biopharmaceutical company developing drugs against hepatitis.